Aker Biomarine withdraws patent lawsuit against Rimfrost

Yesterday, Aker Biomarine voluntarily withdrew its complaint at the International Trade Commission (ITC), alleging that krill manufacturer Rimfrost had violated several of its patents.

“This is good news, showing that we have been right all along. Aker Biomarine has no case, because you cannot patent nature itself”, says owner Stig Remøy.

Aker Biomarine’s patent dispute with Rimfrost has had negative effects on the global krill market. As the ITC case closes, new market opportunities for Rimfrost are emerging.

“Rimfrost’s ambitions with krill are extensive. Our considerable krill oil capacities allow us to market worldwide. In addition, krill has major potential in the aquaculture market. Our technology increases growth and improves health for farmed salmon”, Remøy says.

Without succeeding, Aker Biomarine has, over time, acted aggressively towards Rimfrost. As Aker Biomarine has now unilaterally withdrawn its ITC complaint, the U.S. Patent Trial and Appeal Board (PTAB) will consider four of Rimfrost’s petitions against Aker Biomarine’s patents.

“We are observing that Aker Biomarine adopts harsh methods in an attempt to usurp a global krill monopoly. This will not succeed, and cannot be accepted by us. When krill licenses were allocated in 2007, Norwegian authorities made it clear that it is in the nation's interest that licenses are distributed to multiple players”, Remøy says.

For further information, please contact:

Owner Stig Remøy

RIMFROST AS

+47 916 19 124

For additional information, please contact:

July 24, 2017
Aker ASA misinforms the market in their Q2 report

In their second quarter report 2017, Aker ASA misinforms the market about Aker Biomarines ownership in patents and intellectual property rights in connection with the purchase of F/T Juvel.

April 27, 2017
RIMFROST: Global krill demand increases, plans new vessel.

Norwegian krill manufacturer RIMFROST notes that the global demand for krill oil for human consumption increases, and begins the planning of a new vessel. “After several challenging years, the global krill market is now showing real signs of recovery”, owner of RIMFROST, Stig Remøy, says.

April 26, 2017
RIMFROST obtains regulatory approval in China

RIMFROST AS is a Norwegian biotechnology company which supplies its RIMFROST Sublime krill oil to the world’s food supplement markets. The company is experiencing increasing sales and market share growth, especially the USA and Europe. The strategy of RIMFROST is now to expand into China and offer a high quality krill oil with superior color and viscosity which meets the regulatory requirements of Chinese authorities. As a first step RIMFROST has been successful in obtaining regulatory approval from the National Health and Family Planning Commission (NHFMC).

April 20, 2017
Aker Biomarine withdraws patent lawsuit against Rimfrost

Yesterday, Aker Biomarine voluntarily withdrew its complaint at the International Trade Commission (ITC), alleging that krill manufacturer Rimfrost had violated several of its patents.

December 22, 2016
Merry Christmas from Rimfrost

As the Holiday Season is upon us, the RIMFROST TEAM wants to wish you a very Merry Christmas and a New Year filled with peace and prosperity.

October 1, 2016
Visit us at the Supply Side West show in Las Vegas 6. - 7. October 2016

We are attending this years Supply Side West show and hope to see you there. Stop by our booth #PP165 and lets talk krill.

September 30, 2016
RIMFROST KRILL POWDER MAY BE EFFECTIVE IN IMPROVING VASCULAR HEALTH

RIMFROST in collaboration with partners in New Zealand has developed and patented a krill powder for human nutraceutical applications. In a long term collaboration with the University in Bergen, with the financial support from the Norwegian Research Council, krill products have been tested in animal models and in humans and the results have been published in international scientific journals. The most recent data shows that krill powder is effective in reducing atherosclerosis in apo E-/- mice, suggesting that it also may be effective in improving vascular health in humans.

September 22, 2016
RIMFROST KRILL OIL RECEIVES REGULATORY APPROVAL IN BRAZIL

RIMFROST AS is a Norwegian vertically integrated krill company which offers krill oil and krill powder to worlds food supplement markets. The company’s strategy to offer this product in South America has now reached a milestone as the company has been granted regulatory approval in Brazil.

July 13, 2016
RIMFROST SUBLIME 60PL obtains regulatory approval for the EU market.

RIMFROST AS is a Norwegian vertically integrated biotechnology company that operates and controls the production of high quality krill products from raw material to finished capsules. The company’s recent innovation, a 100% pure krill oil extract with 60% phospholipids, has now obtained a favourable opinion from the Finnish Novel Food Board based on substantial equivalence and is therefore ready for the European market.

New studies confirm the high stability of Rimfrost Pristine krill powder

In a collaboration with NOFIMA and Denmark Technical University, two stability studies have been performed, showing that the krill powder is stable and minimal degradation takes place.

March 30, 2015
CLINICAL STUDY SHOWS THAT BIOAVAILABILITY OF EPA/DHA FROM KRILL OIL IS SUPERIOR TO FISH OIL

RIMFROST AS has published a randomized, single-dose, cross-over trial in Lipids in Health and Disease which documents the bioavailability of fatty acids from RIMFROST krill products and fish oil in healthy humans.

August 21, 2015
OLYMPIC SEAFOOD'S KRILL FISHERY RECEIVES MARINE STEWARDSHIP COUNCIL (MSC) CERTIFICATION

Olympic Seafood AS has today received confirmation that its krill fishery is now certified by the Marine Stewardship Council (MSC).